However, BRSK2 mRNA levels were not altered by CREB knockdown with cisplatin treatment, except in H1299 tumor spheroids (Fig. S4B), suggesting that BRSK2 is unlikely to be a direct transcriptional target of CREB. This evidence concerns the gene BRSK2 and neoplasm.